Related Experiment Video
Updated: Jul 4, 2025
03:53
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
1.2K
Coronavirus Disease-2019 in the Immunocompromised Host
Christopher D Bertini1, Fareed Khawaja2, Ajay Sheshadri3
1Department of Internal Medicine, UTHealth Houston McGovern Medical School, 6431 Fannin, MSB 1.150, Houston, TX 77030, USA.
Infectious Disease Clinics of North America
|January 27, 2024
Summary
Immunocompromised patients face severe outcomes from COVID-19, including higher hospitalization and mortality rates. Current treatments and vaccines show variable effectiveness, highlighting the need for specific strategies for this vulnerable population.
Area of Science:
- Infectious Diseases and Virology
- Immunology
- Public Health
Background:
- Immunocompromised individuals, including those with malignancies, undergoing transplants, or with autoimmune diseases, are at increased risk for severe COVID-19.
- This population experiences disproportionately higher morbidity and mortality rates from coronavirus disease-2019 (COVID-19) compared to immunocompetent individuals.
- Existing therapeutic and prophylactic measures like vaccines and monoclonal antibodies demonstrate limited and variable efficacy in immunocompromised hosts.
Purpose of the Study:
- To review the specific impact of COVID-19 on immunocompromised patient populations.
- To identify and analyze the current gaps in knowledge regarding COVID-19 management in immunocompromised individuals.
- To highlight areas requiring further research for improved patient outcomes.
Main Methods:
- Comprehensive literature review focusing on studies detailing COVID-19 in immunocompromised hosts.
- Analysis of data on disease severity, hospitalization, and mortality rates in relation to immune status.
- Evaluation of the effectiveness of current interventions, including vaccines, monoclonal antibodies, and convalescent plasma.
Main Results:
- Immunocompromised patients exhibit significantly more severe COVID-19 illness, leading to higher rates of hospitalization and death.
- The efficacy of available vaccines, monoclonal antibodies, and convalescent plasma therapies is inconsistent across different immunocompromised subgroups.
- There is a lack of established, tailored treatment guidelines specifically for immunocompromised individuals with COVID-19.
Conclusions:
- Immunocompromised patients represent a critical population with heightened vulnerability to severe COVID-19 outcomes.
- Current therapeutic and preventive strategies are variably effective, underscoring an urgent need for specialized approaches.
- Further research is essential to address knowledge gaps and develop targeted interventions for this patient group.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.8K
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
1.3K
Related Concept Videos
01:25Immunodeficiency Diseases
940
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
940
01:26Factors Affecting the Risk of Infection
11.8K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.8K
01:29Pulmonary Tuberculosis I
243
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243
01:26Stages of Infection
56.5K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
56.5K
01:25Transmission-based Precautions II: Airborne and Protective Environment
1.3K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K
01:30Pneumonia I: Introduction
239
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
239